CaaS Capital Management: Funding, Team & Investors | Startup Intros

Loading organizations...

CaaS Capital Management: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Nov 1, 2021	HotSpot Therapeutics	$100.0M Series C	Pivotal bioVenture Partners	AbbVie Ventures, Access Biotechnology, Atlas Venture, EQT Life Sciences, Novo Ventures, RiverVest, Roche Venture Fund, Samsara BioCapital, Soffinova Partners, SR One, B Capital Group, Fouad Azzam, Ph.D., Monashee Investment Management, MRL Ventures Fund, Pavilion Capital, Revelation Partners, Tekla Capital Management
Aug 1, 2021	T-knife	$110.0M knife - Series B	Fidelity Management & Research Company	Andera Partners, Forbion, Versant Ventures, Steve Weinstein, Casdin Capital, Karin Kleinhans, Qatar Investment Authority, RA Capital Management, Sixty Degree Capital
Jul 1, 2021	Artios Pharma	$150.0M Series C	Michelle Doig, Chen Yu	Andera Partners, EQT Life Sciences, Hakan Goker, M Ventures (Merck), Novartis Venture Fund, Pfizer Venture Investments, Arix Bioscience, Avidity Partners, Deep Track Capital, Invus, LSP, Novartis, Piper Heartland Healthcare Capital, RTW Investments, Schroders Capital, Sofinnova Partners, Soleus Capital, SV Health Investors, Tetragon Financial Group
Jul 1, 2021	Turnstone Biologics	$80.0M Series D	Santhosh Palani, PhD, CFA, Point72	KohFounders, Sofinnova Investments, venBio, Venrock, Versant Ventures, 404 Bio, Brace Pharma Capital, Eventide Asset Management, F-Prime Capital, JM Family Enterprises, Northleaf Capital Partners, OrbiMed, Ridgeback Capital Investments, Sectoral Asset Management, Sixty Degree Capital, Surveyor Capital, Takeda Ventures, Teralys Capital
Apr 1, 2021	Arcellx	$120.0M Series C	Samsara BioCapital, CAM Capital	Genoa Ventures, Adage, Asymmetry Ventures, Cambrian Biopharma, LG Tech, NEA, Novo Holdings, Sixty Degree Capital, SR One, Surveyor Capital, Suvretta Capital Management, Takeda Ventures, Terra Magnum Capital Partners
Mar 16, 2021	Rapid Micro Biosystems	$81.0M Other Equity	D1 Capital Partners	Adage Capital Management, Ally Bridge Group, Asahi Kasei Medical, Bain Capital Life Sciences, BlackRock, Endeavour Vision, Longitude Capital, Quaker Partners, Sunley House Capital, T. Rowe Price Associates, Xeraya Capital
Mar 1, 2021	Amunix	$120.0M Series B	Viking Global Investors	Frazier Healthcare Partners, ArrowMark Partners, Avidity Partners, Bain Capital Life Sciences, BlackRock, Casdin Capital, Franklin Templeton, Janus Henderson Investors, Longitude Capital, Omega Funds, Polaris Partners, Redmile Group, Venrock
Mar 1, 2021	StrideBio	$82.0M Series B	Northpond Ventures, Novo Ventures	Advanced Technology Ventures, RA Capital, Venrock, Alexandria Venture Investments, Hatteras Venture Partners, Octagon Capital, Pontifax, Sarepta Therapeutics, Takeda Ventures, UCB Ventures, UF Innovate Ventures
Feb 1, 2021	Cyteir Therapeutics	$80.0M Series C	Derek DiRocco	Advanced Technology Ventures, Aisling Capital, Dolby Family Ventures, Novo Ventures, RA Capital, Venrock, Acuta Capital Partners, Ally Bridge Group, Ample Plus Fund, Avidity Partners, Droia Ventures, Janus Henderson Investors, Lightstone Ventures, Osage University Partners
Jan 1, 2021	Werewolf Therapeutics	$72.0M Series B	Derek DiRocco	RA Capital, Adage Capital Management, Arkin Bio Ventures, DC Investment Partners, Elise Wang, HBM Healthcare Investments, Longwood Fund, MPM Capital, Soleus Capital, Sphera Healthcare, Taiho Ventures, UPMC Enterprises